Stockreport

Pfizer Reports 73% Lyme Vaccine Efficacy as Trial Results Complicate Outlook [Yahoo! Finance]

Valneva SE - American Depositary Shares  (VALN) 
PDF Pfizer ( NYSE:PFE ) is approaching a potentially important inflection point in its post-pandemic reset as early data from its Lyme disease vaccine trial begins to take [Read more]